RainDance, Univ. Chicago Sue 10X Genomics for Patent Infringement
RainDance Technologies and the University of Chicago are suing 10X Genomics, alleging it infringes six patents. According to each patent’s abstract, the inventions provide “microfabricated substrates and methods of conducting reactions within these substrates. The reactions occur in plugs transported in the flow of a carrier-fluid.”
Marathon Patent Group (MARA) Unit, SugarSync Enter Settlement, License
Marathon Patent Group announced that its wholly-owned subsidiary, Vantage Point Technology, Inc., has entered in to a settlement and license agreement with SugarSync, Inc. The consideration to be paid by SugarSync to Vantage Point and all other terms of the license agreement are confidential.
Ford, Nissan Hit With Patent Suit Over Hybrid Batteries
Ford Motor Co., Nissan North America Inc. and three auto parts manufacturers were hit with patent infringement suits in Texas federal court Thursday, with Somaltus LLC alleging the companies infringed its patent for battery systems in hybrid vehicles.
Cleveland Biolabs Inc. Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents
Cleveland BioLabs, Inc. today announced the issuance of several new patents for entolimod in the U.S. and other countries, further strengthening its patent position. Cleveland BioLabs, Inc. recently secured two composition of matter patents in the U.S., Patent Numbers 8,871,215 and 8,932,609, that cover the Company’s lead agent, the flagellin-derived entolimod, as well as various other flagellin-derived agents, for any use, including the biodefense indications that CBLI is pursuing.
Johnson & Johnson (JNJ) Confirms USPTO Final Rejection of REMICADE Patent
Johnson & Johnson today announced receipt of a further action from the Patent and Trademark Office regarding the re-examination of U.S. Patent No. 6,284,471 (‘471) relating to REMICADE® issuing a final rejection of the patent.
USPTO issues patent relating to Moberg Pharma’s MOB-015 to treat onychomycosis
USPTO has issued US patent relating to Moberg Pharma’s topical treatment MOB-015 for the treatment onychomycosis. The new patent includes composition of matter claims directed to a new topical formulation of terbinafine, as well as claims directed to methods of treatment of onychomycosis using that new formulation.
AtheroNova Receives Notice of Issuance of Its 3rd US Patent
AtheroNova Inc. today announced that it has received a Notice of Issuance of Patent No. 8952067 titled “Subcutaneous Fat Reduction” by the USPTO with an expiration date of June 20, 2032.
WiLAN and Firetide Sign License Renewal
Open Network Solutions Inc. a wholly-owned subsidiary of WiLAN, has granted Yamaha Corporation and Yamaha Corporation of America, Inc., a license to patented technologies that relate to networking capabilities
Read More
Apricus Biosciences Announces Patent Award for RayVa Investigational Scleroderma Therapy
Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, announced the grant of patent to RayVa, a product candidate being developed by Apricus Biosciences for the treatment of Raynaud’s phenomenon (RP), including the treatment of the condition secondary to Scleroderma.
Apple’s clever idea for making your iPhone’s camera even better
A new patent details a proposed technology called “Mirror Tilt Actuation” that aims to help your camera maintain high picture quality even if you aren’t holding it steady by adjusting it for your hand’s movements. This new technology will be an improvement upon the existing Optical Image Stabilization (OIS) technology that was used with the iPhone 6 Plus.
